Prescribe by brand.
Subcutaneous preparation:
Ozempic
GREEN - Ozempic is the preferred weekly GLP1 for type 2 diabetes. Use in patients who require a weekly GLP1 preparation.
Use of weekly preparation include:
See local type 2 guidance. Semaglutide has the added benefit of positive cardiovascular outcomes in clinical trials. (Decision date - Dec 2022)
Wegovy
RED: NICE TA875 - Wegovy is the preferred brand for managing overweight and obesity in adults. (Decision date - April 2023)
DNP: NICE TA910 - Semaglutide (Wegovy) for managing overweight and obesity in young people aged 12 to 17 years (terminated appraisal). (Decision date - Aug 2023)
Oral preparation:
GREEN - Rybelsus once daily oral preparation for type 2 diabetes (Decision date - February 2024)